Developing Pet Agents for Imaging Phosphodiesterase 10a (pde10a)
Description: PUBLIC HEALTH RELEVANCE: Huntington's disease is a progressive neurological disorder of motor, cognitive, and psychiatric disturbances. It was reported more than 15,000 Americans have HD. At least other 150,000 have a 50% risk of developing the disease and thousands more of their relatives live with the possibility that they might develop HD. A PET radiotracer of PDE10A may help physician to quantify the progression of Huntington Disease based on the PET measurement of PDE10A level in patients with the Huntington disease patients.
Funding type: research
Funder scheme: R33
Start date: 2011-02-01
End date: 2018-01-31
Investigator: ZHUDE TU
Institution: WASHINGTON UNIVERSITY
Subfield: Molecular Biology
Domain: Life Sciences
Funded outputs count: 54
Funder award ID: R33MH092797
OpenAlex ID: G4009729327
